Gresham is a independent Australian investment and advisory house with offices in Sydney, Melbourne and Perth. The Group focuses on four key business areas including Corporate Advisory, Private Equity, Property and Asset Finance.
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2002-11-12 | Smart Drug Systems | Series B | $6M | Arrow Capital, Bay City Capital, GBS Venture Partners, Gilde Investment Management, and Taraval Associates |
| 1999-11-15 | Smart Drug Systems | Series A | $5M | Bay City Capital, and Gilde Investment Management |
| AquaSpy | Other Investors | Centre for Energy and Greenhouse Technologies, Cleantech Ventures, Colonial First State Global Asset Management, and Nanyang Ventures |
